中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

从Baveno Ⅵ共识看肝硬化食管胃底静脉曲张的个体化治疗

张春清 李晶

张春清, 李晶. 从Baveno Ⅵ共识看肝硬化食管胃底静脉曲张的个体化治疗[J]. 临床肝胆病杂志, 2016, 32(2): 242-244. DOI: 10.3969/j.issn.1001-5256.2016.02.008
引用本文: 张春清, 李晶. 从Baveno Ⅵ共识看肝硬化食管胃底静脉曲张的个体化治疗[J]. 临床肝胆病杂志, 2016, 32(2): 242-244. DOI: 10.3969/j.issn.1001-5256.2016.02.008
Zhang ChunQing, Li Jing. Individualized treatment of liver cirrhosis and esophageal and gastric varices from the perspective of Baveno Ⅳ[J]. J Clin Hepatol, 2016, 32(2): 242-244. DOI: 10.3969/j.issn.1001-5256.2016.02.008
Citation: Zhang ChunQing, Li Jing. Individualized treatment of liver cirrhosis and esophageal and gastric varices from the perspective of Baveno Ⅳ[J]. J Clin Hepatol, 2016, 32(2): 242-244. DOI: 10.3969/j.issn.1001-5256.2016.02.008

从Baveno Ⅵ共识看肝硬化食管胃底静脉曲张的个体化治疗

DOI: 10.3969/j.issn.1001-5256.2016.02.008
详细信息
  • 中图分类号: R575.21

Individualized treatment of liver cirrhosis and esophageal and gastric varices from the perspective of Baveno Ⅳ

  • 摘要: 门静脉高压治疗经历了外科手术、内镜下硬化剂注射、套扎治疗、组织胶栓塞和放射介入等治疗手段,使门静脉高压相关病死率显著降低;BavenoⅥ以门静脉高压风险评估及个体化管理为主题,强调患者分层和个体化治疗。以BavenoⅥ共识为基础,简述了肝静脉压力梯度、肝功能储备状态及"胃肾分流"等特征参数在静脉曲张出血和预防中的应用进展。

     

  • [1]de FRANCHIS R.Expanding consensus in portal hypertension:report of the Baveno VI Consensus Workshop:stratifying risk and individualizing care for portal hypertension[J].J Hepatol,2015,63(3):743-752.
    [2]KAMATH PS,MOOKERJEE RP.Individualized care for portal hypertension:Not quite yet[J].J Hepatol,2015,63(3):543-545.
    [3]BURROUGHS AK,THALHEIMER U.Hepatic venous pressure gradient in 2010:optimal measurement is key[J].Hepatology,2010,51(6):1894-1896.
    [4]LI Z,ZHANG CQ.Clinical application of hepatic venous pressure gradient[J/CD].Chin J Digest Med Imageol:Electronic Edition,2013,3(3):1-3.(in Chinese)李振,张春清.肝静脉压力梯度测定的临床应用[J/CD].中华消化病与影像杂志:电子版,2013,3(3):1-3.
    [5]ADDLEY J,THAM TC,CASH WJ.Use of portal pressure studies in the management of variceal haemorrhage[J].World J Gastrointest Endosc,2012,4(7):281-289.
    [6]LI ZF,JIANG A,ZHANG S.Exploration and practice of individualized treatment strategies for cirrhotic portal hypertension[J/CD].Chin J Hepatic Surg:Electronic Edition,2015,4(3):146-149.(in Chinese)李宗芳,蒋安,张澍.肝硬化门静脉高压症个体化治疗策略的探索与实践[J/CD].中华肝脏外科手术学:电子杂志,2015,4(3):146-149.
    [7]KANG EJ,JEONG SW,JANG JY,et al.Long-term result of endoscopic Histoacryl(N-butyl-2-cyanoacrylate)injection for treatment of gastric varices[J].World J Gastroenterol,2011,17(11):1494-1500.
    [8]SAAD WE,KHAJA MS,HIROTA S.Balloon-occluded retrograde transvenous obliteration of gastric varices:conception,evolution,and history[J].Tech Vasc Interv Radiol,2012,15(3):160-164.
    [9]SARASWAT VA,VERMA A.Gluing gastric varices in 2012:lessons learnt over 25 years[J].Tech Vasc Interv Radiol,2012,2(1):55-69.
    [10]WU L,LI LH,ZHANG CQ,et al.Percutaneous trans-hepatic cyanoacrylate embolization forgastricvarices[J].Chin J Dig Endosc,2009,11(11):580-583.(in Chinese)吴蕾,李兰花,张春清,等.经皮经肝胶栓塞治疗胃静脉曲张的疗效分析[J].中华消化内镜杂志,2009,11(11):580-583.
  • 加载中
计量
  • 文章访问数:  67
  • HTML全文浏览量:  24
  • PDF下载量:  329
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-12-02
  • 出版日期:  2016-02-20
  • 刊出日期:  2016-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回